이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Delta Pocc During Spontaneous Breathing Trial to Predict Extubation Failure in Mechanically Ventilated Adults (DELTA-EXT) (DELTA-EXT)

2026년 6월 22일 업데이트: Musso Gabriel Andres, Sanatorio Parque, Argentina

Prospective Observational Single-Center Physiological Study Evaluating Dynamic Stress Estimated by Delta Pocc During a Pressure Support Spontaneous Breathing Trial (PSV 8 cmH2O, PEEP 0 cmH2O) as a Predictor of Extubation Failure in Mechanically Ventilated Adult ICU Patients

This prospective observational single-center study will evaluate whether dynamic respiratory stress estimated by delta airway occlusion pressure deflection (Delta Pocc) during a standardized spontaneous breathing trial can predict extubation failure in mechanically ventilated adult intensive care unit patients.

Liberation from invasive mechanical ventilation is a critical step in ICU care. Although spontaneous breathing trials are routinely used to assess readiness for extubation, some patients may successfully complete the trial despite experiencing excessive respiratory effort and physiological stress, which may increase the risk of extubation failure.

This study will include adult ICU patients who have received invasive mechanical ventilation for at least 24 hours and are considered ready for a spontaneous breathing trial according to the treating clinical team. During the trial, respiratory, ventilatory, and hemodynamic variables will be recorded at predefined time points, including measurements of Delta Pocc as a non-invasive estimate of inspiratory effort and dynamic stress.

The primary outcome is extubation failure within 48 hours after extubation, defined as reintubation and/or the need for rescue non-invasive respiratory support due to post-extubation respiratory deterioration.

The study aims to determine whether this physiological measurement may improve risk stratification during weaning and complement conventional clinical decision-making.

연구 개요

상세 설명

Background

Liberation from invasive mechanical ventilation requires integration of clinical, hemodynamic, gas exchange, and physiological criteria. The spontaneous breathing trial (SBT) is a standard component of the weaning process and is commonly used to assess readiness for extubation. However, conventional clinical parameters may not fully capture the true respiratory workload experienced by the patient during the trial.

Some patients may tolerate a spontaneous breathing trial according to standard criteria while still developing excessive inspiratory effort and elevated dynamic respiratory stress, potentially predisposing them to post-extubation respiratory failure. Identifying these patients before extubation remains a major clinical challenge.

Delta airway occlusion pressure deflection (Delta Pocc), obtained during a brief expiratory occlusion maneuver, has emerged as a non-invasive physiological surrogate for inspiratory effort and dynamic transpulmonary stress. Incorporating this measurement into routine spontaneous breathing trial assessment may improve identification of patients at increased risk of extubation failure.

Objective

The primary objective of this study is to evaluate the predictive ability of Delta Pocc measured during a standardized spontaneous breathing trial to identify patients at risk of extubation failure within 48 hours.

Secondary objectives include:

To describe the temporal evolution of Delta Pocc and other respiratory physiological variables during the spontaneous breathing trial.

To compare respiratory effort and physiological measurements between patients with successful extubation and those with extubation failure.

To explore the discriminatory performance of Delta Pocc compared with conventional weaning variables.

To evaluate associations between Delta Pocc and clinically relevant outcomes including reintubation, rescue respiratory support, ICU length of stay, hospital length of stay, and mortality.

Study Design

This is a prospective, observational, single-center physiological study conducted in the adult intensive care unit of Sanatorio Parque.

The study does not modify standard clinical management. Participation will not delay extubation decisions or replace the clinical judgment of the treating team.

Study Population

Adult ICU patients receiving invasive mechanical ventilation for at least 24 hours who meet clinical criteria for a spontaneous breathing trial according to routine clinical practice will be eligible.

Inclusion Criteria Age 18 years or older Invasive mechanical ventilation for at least 24 hours Clinical indication for spontaneous breathing trial Hemodynamic and clinical stability Technical feasibility for physiological measurements Exclusion Criteria Significant hemodynamic instability Severe uncontrolled hypoxemia Major arrhythmias Agitation or patient-ventilator asynchrony preventing reliable measurements Significant air leak Technical inability to perform expiratory occlusion maneuver Limitation of life-sustaining treatment Procedures

Baseline respiratory, ventilatory, and hemodynamic variables will be recorded under current ventilatory settings.

A standardized spontaneous breathing trial will then be performed using:

Pressure support ventilation (PSV): 8 cmH2O Positive end-expiratory pressure (PEEP): 0 cmH2O

Measurements will be recorded at:

Baseline 15 minutes 30 minutes

Collected variables include:

Delta Pocc P0.1 Estimated inspiratory muscle pressure Negative inspiratory force Respiratory rate Rapid shallow breathing index Minute ventilation Peak airway pressure Mean airway pressure Oxygen saturation Heart rate Blood pressure Mean arterial pressure Fraction of inspired oxygen

Extubation decisions, preventive non-invasive respiratory support, rescue respiratory support, and reintubation will remain entirely at the discretion of the treating clinical team according to institutional practice.

Outcomes Primary Outcome

Extubation failure within 48 hours after extubation, defined as:

Reintubation, and/or Rescue non-invasive respiratory support due to respiratory deterioration after extubation Secondary Outcomes Spontaneous breathing trial success or failure Cause of spontaneous breathing trial failure Preventive non-invasive respiratory support Reintubation Rescue non-invasive respiratory support Duration of mechanical ventilation ICU length of stay Total hospital length of stay In-hospital mortality Statistical Considerations

The study is designed to evaluate the discriminative performance of Delta Pocc as a predictor of extubation failure.

Receiver operating characteristic (ROC) analysis will be used to assess predictive performance. Repeated physiological measurements will be analyzed using appropriate repeated-measures statistical methods. Multivariable logistic regression may be performed if the number of outcome events is sufficient.

A planned sample size of approximately 110 to 120 patients is expected to provide adequate event capture for exploratory predictive modeling.

Safety

This is a minimal-risk observational study. The only study-specific physiological maneuver is a brief expiratory occlusion measurement performed within standard ventilatory monitoring conditions.

No investigational drugs or devices are involved.

연구 유형

관찰

등록 (추정된)

120

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

  • 이름: Gabriel A Musso, PT, MSc
  • 전화번호: +54 9 3413068143
  • 이메일: udikcar@ugr.edu.ar

연구 연락처 백업

  • 이름: Maria C Gomez, PT, MSc
  • 전화번호: +54 9 3415462918
  • 이메일: cgomez@ugr.edu.ar

연구 장소

    • Santa Fe Province
      • Rosario, Santa Fe Province, 아르헨티나, 2000
        • Sanatorio Parque
        • 연락하다:
          • Gabriel A Musso, PT, MSc
          • 전화번호: +54 9 3413068143
          • 이메일: gmusso@ugr.edu.ar
        • 연락하다:
        • 부수사관:
          • Maria C Gomez, PT, MSc
        • 부수사관:
          • Gabriel Appendino, PT, MSc
        • 부수사관:
          • Martin J Managó, PT, MSc
        • 부수사관:
          • Matias Basso, PT, MSc
        • 부수사관:
          • Axel Rubies, PT, MSc
        • 부수사관:
          • Emanuel Giardini, PT, MSc

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

샘플링 방법

비확률 샘플

연구 인구

Adult intensive care unit patients receiving invasive mechanical ventilation for at least 24 hours who are considered clinically ready for a spontaneous breathing trial as part of routine weaning assessment.

설명

Inclusion Criteria:

  • Age 18 years or older
  • Invasive mechanical ventilation for at least 24 hours
  • Clinical indication for spontaneous breathing trial according to the treating clinical team
  • Hemodynamic and clinical stability
  • Technical feasibility for respiratory physiological measurements, including expiratory occlusion maneuver

Exclusion Criteria:

  • Significant hemodynamic instability
  • Severe uncontrolled hypoxemia
  • Major cardiac arrhythmias
  • Agitation or patient-ventilator asynchrony preventing reliable measurements
  • Significant air leak interfering with respiratory measurements
  • Technical inability to perform expiratory occlusion maneuver
  • Limitation of life-sustaining treatment
  • Incomplete primary outcome follow-up

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

코호트 및 개입

그룹/코호트
개입 / 치료
Mechanically Ventilated Adult ICU Patients Undergoing Spontaneous Breathing Trial
Delta airway occlusion pressure deflection will be measured during a standardized spontaneous breathing trial using pressure support ventilation of 8 cmH2O and PEEP of 0 cmH2O. Delta Pocc will be obtained through a brief expiratory occlusion maneuver and analyzed as a non-invasive physiological estimate of inspiratory effort and dynamic respiratory stress. The measurement will not replace clinical judgment or modify standard extubation decisions.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Number of Participants With Extubation Failure Within 48 Hours
기간: Within 48 hours after extubation
Number of participants experiencing extubation failure, defined as reintubation and/or the need for rescue non-invasive respiratory support due to respiratory deterioration after extubation.
Within 48 hours after extubation

2차 결과 측정

결과 측정
측정값 설명
기간
Change in Delta Pocc During the Spontaneous Breathing Trial
기간: Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
Delta airway occlusion pressure deflection (Delta Pocc) measured at baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial. The change from baseline and the highest value recorded during the trial will be analyzed.
Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
P0.1 During the Spontaneous Breathing Trial
기간: Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
Airway occlusion pressure measured 100 milliseconds after the onset of inspiration (P0.1) at baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial.
Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
Number of Participants Requiring Reintubation
기간: Within 48 hours after extubation
Number of participants requiring reintubation due to post-extubation respiratory failure.
Within 48 hours after extubation
Number of Participants Requiring Rescue Non-Invasive Respiratory Support
기간: Within 48 hours after extubation
Number of participants requiring rescue non-invasive ventilation (NIV) and/or high-flow nasal oxygen therapy (HFNO) because of respiratory deterioration following extubation.
Within 48 hours after extubation
Intensive Care Unit Length of Stay
기간: Through ICU discharge, an average of 30 days
Total number of days spent in the intensive care unit from ICU admission until ICU discharge.
Through ICU discharge, an average of 30 days
Number of Participants Who Died During Hospitalization
기간: Through hospital discharge, an average of 60 days
Number of participants who died during the index hospitalization.
Through hospital discharge, an average of 60 days

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Gabriel A Musso, PT, MSc, Sanatorio Parque

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 8월 1일

기본 완료 (추정된)

2027년 8월 1일

연구 완료 (추정된)

2027년 8월 1일

연구 등록 날짜

최초 제출

2026년 5월 27일

QC 기준을 충족하는 최초 제출

2026년 6월 2일

처음 게시됨 (실제)

2026년 6월 9일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 6월 25일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 6월 22일

마지막으로 확인됨

2026년 6월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • SP-DELTAPOCC-EXTFAIL-2026 (기타 식별자: Sanatorio Parque)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

Individual participant data are not planned to be shared because this is a single-center observational study and no formal institutional data-sharing infrastructure is currently in place. De-identified aggregate study results will be reported in scientific publications.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다